project id: TCGA-ESCA; case submitter id: TCGA-R6-A6DQ; source center: 23; state: released; a260 a280 ratio: 1.42; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.35; rna integrity number: 7.5; age at index: 74; days to birth: -27098; days to death: 231; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Dead; year of birth: 1936; year of death: 2010; age at diagnosis: 27098; ajcc clinical m: M0; ajcc clinical n: N1; ajcc clinical stage: Stage IIIA; ajcc clinical t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C15.5; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower third of esophagus; synchronous malignancy: No; tissue or organ of origin: Lower third of esophagus; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: not reported; alcohol history: Yes; is ffpe: false; weight: 5.0; composition: Not Reported; days to collection: 876; days to sample procurement: 0; initial weight: 5.0; sample id: 184cfa7d-86d4-4505-9226-249a2a205f3b; sample submitter id: TCGA-R6-A6DQ-01B; portion id: 931f7c56-6ba3-499a-8018-8499b6dd838d; portion submitter id: TCGA-R6-A6DQ-01B-11; slide id: fdf43092-2537-448f-bf88-2709302534d1; slide submitter id: TCGA-R6-A6DQ-01Z-00-DX1; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 0.0; percent neutrophil infiltration: 20.0; percent normal cells: 0.0; percent stromal cells: 20.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0; section location: TOP;